BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 9210895)

  • 1. Three decades' experience in surgery of hepatocellular carcinoma.
    Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():126-33. PubMed ID: 9210895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis.
    Tang Z; Zhou X; Lin Z; Yang B; Ma Z; Ye S; Wu Z; Fan J; Liu Y; Liu K; Qin L; Tian J; Sun H; He B; Xia J; Qiu S; Zhou J
    Chin Med J (Engl); 1999 Oct; 112(10):887-91. PubMed ID: 11717970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and prospects in hepatocellular carcinoma surgery.
    Tang ZY; Yu YQ; Zhou XD; Ma ZC; Wu ZQ
    Ann Chir; 1998; 52(6):558-63. PubMed ID: 9752506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma.
    Tang ZY; Zhou XD; Ma ZC; Wu ZQ; Fan J; Qin LX; Yu Y
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):495-8. PubMed ID: 15567731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality treatment in advanced primary liver cancer.
    Zhou XD; Tang ZY; Yu YQ; Yang BH; Lu JZ; Lin ZY; Ma ZC
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():286-9. PubMed ID: 7544966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical treatment of 1450 patients with hepatocellular carcinoma].
    Tang ZY
    Zhonghua Wai Ke Za Zhi; 1992 Jun; 30(6):325-8, 381. PubMed ID: 1337509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of one hundred and twenty five patients with primary liver cancer surviving more than five years.
    Tang ZY; Yu YQ; Zhou XD; Ma ZC; Yang BH; Lu JZ; Lin HY; Tang CL
    Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1202-6. PubMed ID: 1514834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term results of multimodality treatment in patients with primary liver cancer].
    Zhou X; Tang Z; Yu Y
    Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):518-21. PubMed ID: 9594152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma].
    Mo QG; Liang AM; Yang NW; Zhao YN; Yuan WP
    Ai Zheng; 2003 Feb; 22(2):189-91. PubMed ID: 12600298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].
    Lin Z; Ren Z; Xia J
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):315-7. PubMed ID: 11778559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience.
    Yamashita Y; Taketomi A; Itoh S; Kitagawa D; Kayashima H; Harimoto N; Tsujita E; Kuroda Y; Maehara Y
    J Am Coll Surg; 2007 Jul; 205(1):19-26. PubMed ID: 17617328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment of recurrent hepatocellular carcinoma.
    Zhou XD; Yu YQ; Tang ZY; Yang BH; Lu JZ; Lin ZY; Ma ZC; Xu DB; Zhang BH; Zheng YX
    Hepatogastroenterology; 1993 Aug; 40(4):333-6. PubMed ID: 8406302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
    Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hepatocellular carcinoma: long-term outcome in 2639 cases.
    Zhou XD; Tang ZY
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():9-16. PubMed ID: 9210883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Small hepatocellular carcinoma (HCC) and its remote outcome].
    Tang ZY; Yu YQ
    Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):118-20. PubMed ID: 2820680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
    Bhaijee F; Locketz ML; Krige JE
    S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
    J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.